HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.
BörsenkürzelBEAT
Name des UnternehmensHeartbeam Inc
IPO-datumOct 14, 2021
CEOMr. Robert P. (Rob) Eno
Anzahl der mitarbeiter21
WertpapierartOrdinary Share
GeschäftsjahresendeOct 14
Addresse2118 Walsh Ave., Suite 210
StadtSANTA CLARA
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl95050
Telefon14088994443
Websitehttps://www.heartbeam.com/
BörsenkürzelBEAT
IPO-datumOct 14, 2021
CEOMr. Robert P. (Rob) Eno
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten